KATHLEEN MCELROY: Open Payments
NPI 1588954549 · CARSON CITY, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$966 in 46 payments from 14 companies in 2025. Trend: 2023 $896 · 2024 $881 · 2025 $966
Food & beverage: $966
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $234 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $136 |
| PFIZER INC. | 6 | $135 |
| Astellas Pharma US Inc | 4 | $116 |
| Amgen Inc. | 4 | $90 |
| Merck Sharp & Dohme LLC | 3 | $62 |
| Lilly USA, LLC | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Edwards Lifesciences Corporation | 1 | $24 |
| Abbott Laboratories | 1 | $23 |
Products named: Ozempic, JARDIANCE, Veozah, NURTEC ODT, MOUNJARO, GARDASIL 9, OTEZLA, KRYSTEXXA.
Industry payments across NV — which companies pay providers there.
